AsiaNet  85933

WASHINGTON, Oct. 6, 2020 /PRNewswire=KYODO JBN/--

Global law firm Greenberg Traurig, LLP (https://www.gtlaw.com/en ), has added

Chia-Feng Lu as a shareholder in its Health Care & FDA Practice

(https://www.gtlaw.com/en/capabilities/health-care-fda-practice )and Life

Sciences & Medical Technology Group

(https://www.gtlaw.com/en/capabilities/life-sciences--medical-technology ). He

will spend most of his time in Washington, D.C. and the Tokyo/Osaka area, but

will also regularly visit the other parts of the U.S., such as Boston; as well

as European countries. Lu focuses his multi-national practice on guiding life

sciences companies and emerging technology companies in non-life sciences field

through the regulatory and transactional law that applies to their products,

technologies, services, and business strategies. He worked on several products

based on Nobel-winning science in the past two decades respectively, and one of

them has successfully reached the blockbuster status.

"Chiafeng brings a unique perspective that enhances our global capabilities in

the health care and FDA space, and adds further depth to our growing

Washington, D.C. team," said Washington, D.C. Shareholder Nancy E. Taylor

(https://www.gtlaw.com/en/professionals/t/taylor-nancy-e ) and Ft. Lauderdale

Shareholder David C. Peck

(https://www.gtlaw.com/en/professionals/p/peck-david-c ), co-chairs of the

firm's Healthcare & FDA Practice, in a joint statement. "Greenberg Traurig's

global platform aligns strategically with his practice and his work in Asia and

the U.S. will serve as an important resource to our clients."

Lu, who represents clients expanding to Asia, also regularly assists companies

entering the U.S. or Europe. He has extensive experience and familiarity with

business practice, the policy and regulatory systems in Asia, with strong

emphasis on North Asia, among others, and often works with clients in local

languages.  Lu also sits on a number of advisory committees to the government,

and has been an adjunct faculty to medical school and business school in

leading institutes.

"Greenberg Traurig's well-respected Health Care & FDA Practice and expansive

global platform will enable me to serve my clients and contribute to the

practice's international presence," Lu said. "The firm's award winning  Global

Corporate Practice (https://www.gtlaw.com/en/capabilities/corporate ),

Government Law & Policy, International Trade, and its equally impressive

Intellectual Property & Technology Practice

(https://www.gtlaw.com/en/capabilities/intellectual-property--technology ),

were especially attractive to me when choosing Greenberg Traurig as the next

step in my career.  This platform can underscore a total solution concept to

deal with this ever fluid global business and policy environment." Lu comes

from Baker McKenzie. He previously worked for a leading biotechnology company

and a top ten pharmaceutical company's headquarter.

"My work with clients with matters before the regulatory agencies and policy

makers in key markets will prove valuable for clients facing uncertain

regulatory hurdles during their global business planning. Because I will be in

Washington, D.C., where many policies with global impacts are being made,

clients will have direct access to me to navigate those uncharted waters," Lu

added. He advises on several strategic transactions and also assists investment

banks, private equity firms, and venture capital groups in their evaluations of

regulatory and policy developments to such uncertainty with respect to novel

technology and compliance.

Lu received his J.D. from the University of Houston Law Center and his B.S., in

Pharmacy from the National Taiwan University. Lu is admitted to practice in the

District of Columbia and New York.

About Greenberg Traurig:

Greenberg Traurig, LLP (GT) has approximately 2,200 attorneys in 40 locations

in the United States, Latin America, Europe, Asia, and the Middle East. GT has

been recognized for its philanthropic giving, diversity, and innovation, and is

consistently among the largest firms in the U.S. on the Law360 400 and among

the Top 20 on the Am Law Global100. The firm's multidisciplinary Health Care &

FDA Practice (https://www.gtlaw.com/en/capabilities/health-care-fda-practice

)provides strategic counsel to a diverse group of companies and other

organizations, helping them to respond proactively to the rapidly changing

healthcare marketplace. It's  Life Sciences & Medical Technology Group

(https://www.gtlaw.com/en/capabilities/life-sciences--medical-technology )

advises clients ranging from start-ups to large multinational public companies

to leading research institutions. Web: http://www.gtlaw.com Twitter:@GT_Law

(https://twitter.com/GT_Law )

Media contact: Lourdes Brezo-Martinez

               martinezl@gtlaw.com

               +1-212-801-2131.

SOURCE:  Greenberg Traurig